Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200434402> ?p ?o ?g. }
- W4200434402 abstract "Individuals with anorexia nervosa (AN) often present with substance use and substance use disorders (SUDs). However, the prevalence of substance use and SUDs in AN has not been studied in-depth, especially the differences in the prevalence of SUDs between AN types [e.g., AN-R (restrictive type) and AN-BP (binge-eating/purge type]. Therefore, this systematic review and meta-analysis aimed to assess the prevalence of SUDs and substance use in AN samples.Systematic database searches of the peer-reviewed literature were conducted in the following online databases: MEDLINE, PsycINFO, Embase, and CINAHL from inception to January 2021. We restricted review eligibility to peer-reviewed research studies reporting the prevalence for either SUDs or substance use in individuals with AN. Random-effects meta-analyses using Freeman-Tukey double arcsine transformations were performed on eligible studies to estimate pooled proportions and 95% confidence intervals (CIs).Fifty-two studies met the inclusion criteria, including 14,695 individuals identified as having AN (mean age: 22.82 years). Random pooled estimates showed that substance use disorders had a 16% prevalence in those with AN (AN-BP = 18% vs. AN-R = 7%). Drug abuse/dependence disorders had a prevalence of 7% in AN (AN-BP = 9% vs. AN-R = 5%). In studies that looked at specific abuse/dependence disorders, there was a 10% prevalence of alcohol abuse/dependence in AN (AN-BP = 15% vs. AN-R = 3%) and a 6% prevalence of cannabis abuse/dependence (AN-BP = 4% vs. AN-R = 0%). In addition, in terms of substance use, there was a 37% prevalence for caffeine use, 29% prevalence for alcohol use, 25% for tobacco use, and 14% for cannabis use in individuals with AN.This is the most comprehensive meta-analysis on the comorbid prevalence of SUDs and substance use in persons with AN, with an overall pooled prevalence of 16%. Comorbid SUDs, including drugs, alcohol, and cannabis, were all more common in AN-BP compared to AN-R throughout. Therefore, clinicians should be aware of the high prevalence of SUD comorbidity and substance use in individuals with AN. Finally, clinicians should consider screening for SUDs and integrating treatments that target SUDs in individuals with AN. Individuals with anorexia nervosa (AN) may also present with substance use or have a substance use disorder (SUDs). Thus, we conducted a systematic review and meta-analysis to determine the prevalence of substance use and substance use disorders in individuals with AN. We examined published studies that reported the prevalence of either substance use or SUDs in individuals with AN. We found that substance use disorders had a 16% prevalence and that drug abuse/dependence disorders had a prevalence of 7% in those with AN. These rates were much higher in individuals with binge-eating/purging type compared to the restrictive AN. However, many specific substance use disorders and substance use types were low in individuals with AN. Nonetheless, clinicians should be aware of the high prevalence of SUD comorbidity and substance use in individuals with AN." @default.
- W4200434402 created "2021-12-31" @default.
- W4200434402 creator A5012744052 @default.
- W4200434402 creator A5019646055 @default.
- W4200434402 creator A5021007954 @default.
- W4200434402 creator A5022798675 @default.
- W4200434402 creator A5033045210 @default.
- W4200434402 creator A5033544052 @default.
- W4200434402 creator A5044303707 @default.
- W4200434402 creator A5054333044 @default.
- W4200434402 creator A5067842513 @default.
- W4200434402 date "2021-12-01" @default.
- W4200434402 modified "2023-10-16" @default.
- W4200434402 title "The prevalence of substance use disorders and substance use in anorexia nervosa: a systematic review and meta-analysis" @default.
- W4200434402 cites W1971191719 @default.
- W4200434402 cites W1979423827 @default.
- W4200434402 cites W1985704237 @default.
- W4200434402 cites W1995254805 @default.
- W4200434402 cites W1999235835 @default.
- W4200434402 cites W2025585387 @default.
- W4200434402 cites W2026188485 @default.
- W4200434402 cites W2028608451 @default.
- W4200434402 cites W2057136526 @default.
- W4200434402 cites W2067156221 @default.
- W4200434402 cites W2069273809 @default.
- W4200434402 cites W2078436067 @default.
- W4200434402 cites W2087282820 @default.
- W4200434402 cites W2094019307 @default.
- W4200434402 cites W2096937635 @default.
- W4200434402 cites W2107328434 @default.
- W4200434402 cites W2107914101 @default.
- W4200434402 cites W2112663200 @default.
- W4200434402 cites W2114488753 @default.
- W4200434402 cites W2114843987 @default.
- W4200434402 cites W2117153542 @default.
- W4200434402 cites W2119231503 @default.
- W4200434402 cites W2125195644 @default.
- W4200434402 cites W2134833483 @default.
- W4200434402 cites W2139888794 @default.
- W4200434402 cites W2142498100 @default.
- W4200434402 cites W2156889285 @default.
- W4200434402 cites W2158433804 @default.
- W4200434402 cites W2161374186 @default.
- W4200434402 cites W2162636537 @default.
- W4200434402 cites W2164638855 @default.
- W4200434402 cites W2252491910 @default.
- W4200434402 cites W2332043567 @default.
- W4200434402 cites W2477735897 @default.
- W4200434402 cites W2502487999 @default.
- W4200434402 cites W2521672452 @default.
- W4200434402 cites W2736920241 @default.
- W4200434402 cites W2743891014 @default.
- W4200434402 cites W2747338508 @default.
- W4200434402 cites W2782613281 @default.
- W4200434402 cites W2908155319 @default.
- W4200434402 cites W2943102357 @default.
- W4200434402 cites W3005675525 @default.
- W4200434402 cites W3014856441 @default.
- W4200434402 cites W3015426792 @default.
- W4200434402 cites W3017279243 @default.
- W4200434402 cites W3111962220 @default.
- W4200434402 cites W3164437855 @default.
- W4200434402 cites W4247665917 @default.
- W4200434402 cites W4250513901 @default.
- W4200434402 cites W47250957 @default.
- W4200434402 cites W66134822 @default.
- W4200434402 cites W998963598 @default.
- W4200434402 doi "https://doi.org/10.1186/s40337-021-00516-3" @default.
- W4200434402 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34895358" @default.
- W4200434402 hasPublicationYear "2021" @default.
- W4200434402 type Work @default.
- W4200434402 citedByCount "9" @default.
- W4200434402 countsByYear W42004344022022 @default.
- W4200434402 countsByYear W42004344022023 @default.
- W4200434402 crossrefType "journal-article" @default.
- W4200434402 hasAuthorship W4200434402A5012744052 @default.
- W4200434402 hasAuthorship W4200434402A5019646055 @default.
- W4200434402 hasAuthorship W4200434402A5021007954 @default.
- W4200434402 hasAuthorship W4200434402A5022798675 @default.
- W4200434402 hasAuthorship W4200434402A5033045210 @default.
- W4200434402 hasAuthorship W4200434402A5033544052 @default.
- W4200434402 hasAuthorship W4200434402A5044303707 @default.
- W4200434402 hasAuthorship W4200434402A5054333044 @default.
- W4200434402 hasAuthorship W4200434402A5067842513 @default.
- W4200434402 hasBestOaLocation W42004344021 @default.
- W4200434402 hasConcept C107130276 @default.
- W4200434402 hasConcept C118552586 @default.
- W4200434402 hasConcept C126322002 @default.
- W4200434402 hasConcept C17744445 @default.
- W4200434402 hasConcept C186079640 @default.
- W4200434402 hasConcept C189708586 @default.
- W4200434402 hasConcept C199539241 @default.
- W4200434402 hasConcept C27415008 @default.
- W4200434402 hasConcept C2776394216 @default.
- W4200434402 hasConcept C2777031586 @default.
- W4200434402 hasConcept C2777056318 @default.
- W4200434402 hasConcept C2779473830 @default.
- W4200434402 hasConcept C2779549880 @default.
- W4200434402 hasConcept C2781145037 @default.
- W4200434402 hasConcept C40010229 @default.